<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><link>https://bsky.app/profile/tubsmedbiotech.bsky.social</link><title>@tubsmedbiotech.bsky.social - </title><item><link>https://bsky.app/profile/tubsmedbiotech.bsky.social/post/3mboag6z6ck2h</link><description>A CD38 &#34;baitbody&#34; to support safe blood products for multiple myeloma patients receiving Daratumumab and Isatuximab.&#xA;https://onlinelibrary.wiley.com/doi/full/10.1155/jimr/7343647/&#xA;&#xA;#baitbody, #daratumumab, #felzartamab, #isatuximab, #transfusionmedicine, #antibody, #fusionprotein, #bloodcompatability, #CD38, #MM</description><pubDate>05 Jan 2026 10:33 +0000</pubDate><guid isPermaLink="false">at://did:plc:goydekh6psrmfpnca5miohyk/app.bsky.feed.post/3mboag6z6ck2h</guid></item></channel></rss>